<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01243723</url>
  </required_header>
  <id_info>
    <org_study_id>2010-021919-17</org_study_id>
    <nct_id>NCT01243723</nct_id>
  </id_info>
  <brief_title>Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With Dyschesia</brief_title>
  <acronym>EDUCDYS</acronym>
  <official_title>Étude Comparative, randomisée, Double-insu, en Groupes parallèles évaluant l'efficacité d'Eductyl® Versus Placebo Chez Des Patients Souffrant d'Une dyschésie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Techni Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Techni Pharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of Eductyl versus placebo for treatment
      of patients with dyschesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia on VAS of intensity of inconfort</measure>
    <time_frame>Day 0 and day 21</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the intensity of inconfort of patients with dyschesia on Likert scale</measure>
    <time_frame>Every day from day 0 to day 21</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the efficacy of Eductyl versus placebo on dyschesia related quality of life</measure>
    <time_frame>Day 0 and day 21</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the efficacy of Eductyl versus placebo on bowel function index</measure>
    <time_frame>Day 0 and day 21</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the efficacy of Eductyl versus placebo on global impression of change</measure>
    <time_frame>Day 21</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the tolerance of Eductyl versus placebo</measure>
    <time_frame>Day 21</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">306</enrollment>
  <condition>Dyschesia</condition>
  <arm_group>
    <arm_group_label>Eductyl suppository</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo suppository</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eductyl suppository</intervention_name>
    <description>One suppository every morning during 21 days</description>
    <arm_group_label>Eductyl suppository</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo suppository</intervention_name>
    <description>One suppository every morning during 21 days</description>
    <arm_group_label>Placebo suppository</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged from 18 to 75 years old,

          -  Writing consent to take part in the study,

          -  Patient with a dyschesia according to Rome III criteria

          -  An intensity of the inconfort using a VAS (0 (no inconfort) to 100 mm (maximal and no
             supportable inconfort)) equal or over 40 mm

        Exclusion Criteria:

          -  Patient suffering of neurologic affection,

          -  Rectal diseases including :

               -  Current anal ou peri-anal pain,

               -  Current organic injury of colon or rectum,

               -  Current anal injury,

               -  Current rectal Prolapse,

               -  Current haemorrhoid,

               -  Colon inflammatory disease (ulcero haemorrhagic recto colitis, Crohn disease…),

               -  Current ano-recto-colon stenosis (anastomosis, scarring ...)

          -  Patient undergone pain killers (WHO level II (except dextropropoxyphen) and III)
             during the last 8 days,

          -  Patient undergone anti-depressants except if this treatment is regular for at least 15
             days and it won't be modified during the study,

          -  Patient with a constipation treatment except if this treatment is regular for at least
             15 days and it won't be modified during the study

          -  Intolerance to Eductyl® or to one of its components (potassium tartarate acid, sodium
             bicarbonate, solid hemisynthethic glycerides, soya lecithin, talc)

          -  Use of Eductyl® during the previous 15 days (over 5 days in the last 15 days),

          -  Patient already included in clinical trial in the last month,

          -  Pregnant or breast feeding woman,

          -  Woman of childbearing potential without contraception,

          -  Patient unable to read and write.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Laure Tarrerias, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Suresnes Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Savarieau, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Nukleus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Foch, Service de Chirurgie Générale et Digestive</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2010</study_first_submitted>
  <study_first_submitted_qc>November 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2010</study_first_posted>
  <last_update_submitted>March 18, 2014</last_update_submitted>
  <last_update_submitted_qc>March 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dyschesia treatment</keyword>
  <keyword>Inconfort related to dyschesia</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Bowel function index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

